Chemring Group PLC |Annual Report and Accounts 2012
Chemring Group PLC |Annual Report and Accounts 2012
Chemring Group PLC |Annual Report and Accounts 2012
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
30<br />
Corporate governance<br />
Directors’ report<br />
for the year ended 31 October <strong>2012</strong><br />
The directors present their annual report, together with the audited<br />
financial statements of the <strong>Group</strong> <strong>and</strong> the Company for the year<br />
ended 31 October <strong>2012</strong>.<br />
Principal activities<br />
The principal activities of the <strong>Group</strong> are the design, manufacture<br />
<strong>and</strong> sale of counter-IED equipment, countermeasures, pyrotechnics<br />
<strong>and</strong> munitions.<br />
Business review<br />
The Chairman’s statement <strong>and</strong> the business review on pages 4<br />
to 27 provide an overview of the <strong>Group</strong>’s business development,<br />
performance <strong>and</strong> position during <strong>and</strong> at the end of the financial<br />
year; its strategy <strong>and</strong> likely future development; key performance<br />
indicators; <strong>and</strong> a description of the principal risks <strong>and</strong> uncertainties<br />
facing the business. Further information regarding financial risk<br />
management policies <strong>and</strong> financial instruments is given in note 24<br />
of the financial statements. There have been no significant events<br />
since the balance sheet date.<br />
Results <strong>and</strong> dividends<br />
The profit attributable to the <strong>Group</strong>’s shareholders for the year was<br />
£15.3 million (2011: £73.9 million). The directors recommend a final<br />
dividend of 4.2p per ordinary share which, together with the interim<br />
dividend of 5.3p per ordinary share paid in August <strong>2012</strong>, gives a<br />
total for the year of 9.5p (2011: 14.8p). The final dividend is subject<br />
to approval by shareholders at the Annual General Meeting on<br />
20 March 2013, <strong>and</strong> accordingly has not been included as a liability<br />
in these financial statements.<br />
Directors <strong>and</strong> their interests<br />
The present directors are shown on pages 28 <strong>and</strong> 29.<br />
Mr D Evans resigned as a director on 21 March <strong>2012</strong>, Mr P Rayner<br />
resigned as a director on 31 July <strong>2012</strong>, <strong>and</strong> Dr D Price resigned as a<br />
director on 23 October <strong>2012</strong>.<br />
Mr M Papworth was appointed as a director on 5 November <strong>2012</strong>,<br />
<strong>and</strong> Mr S Bowers was appointed as a director on 7 January 2013.<br />
Both of these directors will be seeking re-appointment under<br />
Article 87.1 of the Company’s Articles of Association at the<br />
forthcoming Annual General Meeting.<br />
In accordance with the Company’s Articles of Association, all<br />
directors are required to submit themselves for re-election every<br />
three years. However, in order to ensure compliance with the UK<br />
Corporate Governance Code, all directors now voluntarily submit<br />
themselves for re-election at every Annual General Meeting.<br />
Sir Peter Norriss has indicated his intention to retire as a<br />
non-executive director at this year’s Annual General Meeting,<br />
<strong>and</strong> will not therefore be seeking re-election.<br />
Nigel Young, who was Interim Chief Financial Officer between<br />
August <strong>2012</strong> <strong>and</strong> January 2013, will join the Board as a<br />
non-executive director at the end of April 2013. He will become<br />
Chairman of the Audit Committee, succeeding Lord Freeman<br />
who plans to retire from the Board at the end of the year.<br />
Details of the service contracts between the Company <strong>and</strong> the<br />
executive directors are set out in the directors’ remuneration<br />
report on page 41. The non-executive directors do not have service<br />
contracts with the Company.<br />
The Company has made qualifying third party indemnity provisions<br />
for the benefit of its directors, which were in effect throughout the<br />
year <strong>and</strong> remain in force at the date of this report.<br />
None of the directors had a beneficial interest in any contract of<br />
significance to which the <strong>Group</strong> was a party during the year ended<br />
31 October <strong>2012</strong>.<br />
Information required as to directors’ shareholdings is set out in the<br />
directors’ remuneration report.<br />
Substantial shareholdings<br />
At 23 January 2013, the following substantial holdings in the<br />
ordinary share capital of the Company had been notified to the<br />
Company in accordance with Chapter 5 of the Disclosure <strong>and</strong><br />
Transparency Rules of the Financial Services Authority:<br />
Name<br />
% Interest<br />
Invesco Limited 27.5<br />
UBS Global Asset Management 5.5<br />
Old Mutual Asset Managers 5.1<br />
Ameriprise Financial, Inc. 5.1<br />
JP Morgan Chase & Co. 4.9<br />
AXA S.A. <strong>and</strong> its group of companies 4.8<br />
St<strong>and</strong>ard Life Investments Ltd 4.6<br />
BT Pension Scheme Trustees Ltd as Trustees<br />
of the BT Pension Scheme 3.8<br />
Cantillon Capital Management LLC 3.6<br />
Tameside MBC re Greater Manchester Pension Fund 3.4<br />
Hermes Equity Ownership Services Ltd 2.9<br />
Employees <strong>and</strong> employee consultation<br />
Details of the <strong>Group</strong>’s employment policies <strong>and</strong> employee<br />
consultation practices are set out in the corporate responsibility<br />
review on page 25.<br />
Charitable <strong>and</strong> political donations<br />
Charitable donations amounting to £64,000 (2011: £129,000) were<br />
made during the year. No political donations were made during the<br />
year (2011: £nil).<br />
Contractual arrangements<br />
The <strong>Group</strong> contracts with a wide range of customers, comprising<br />
governments, armed forces, prime contractors <strong>and</strong> OEMs across the<br />
globe. The US Department of Defense is the largest single customer,<br />
<strong>and</strong> procures the <strong>Group</strong>’s products under a significant number of<br />
separate contracts placed with individual <strong>Group</strong> businesses.<br />
The <strong>Group</strong>’s businesses utilise many suppliers across the world, <strong>and</strong><br />
arrangements are in place to ensure that businesses are not totally<br />
reliant on single suppliers for key raw materials or components.<br />
Policy on payment of suppliers<br />
It is the policy of the <strong>Group</strong> that each of the <strong>Group</strong> companies<br />
should agree appropriate terms <strong>and</strong> conditions for its transactions<br />
with suppliers. These will range from st<strong>and</strong>ard written terms to<br />
individually negotiated contracts. Creditor days of the <strong>Group</strong> as at<br />
31 October <strong>2012</strong> amounted to 25 days (2011: 29 days).<br />
Share capital <strong>and</strong> shareholder rights<br />
General<br />
The Company’s share capital consists of ordinary shares of 1p<br />
each <strong>and</strong> preference shares of £1 each, which are fully paid-up<br />
<strong>and</strong> quoted on the main market of the London Stock Exchange.<br />
Full details of the movements in the issued share capital of the<br />
Company during the financial year are provided in note 27 of the<br />
financial statements.<br />
<strong>Chemring</strong> <strong>Group</strong> <strong>PLC</strong> <strong>Report</strong> <strong>and</strong> <strong>Accounts</strong> <strong>2012</strong>